My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2016-112
CBCC
>
Official Documents
>
2010's
>
2016
>
2016-112
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
8/22/2016 10:16:54 AM
Creation date
8/22/2016 10:16:53 AM
Metadata
Fields
Template:
Official Documents
Official Document Type
Agreement
Approved Date
08/16/2016
Control Number
2016-112
Agenda Item Number
8.N.
Entity Name
Kannact, Inc.
Subject
Diabetes Management Supplies & Services
Purchase Agreement
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
13
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
d. Supplier estimates the delivered value of a glucometer at $80.00 per unit. <br /> Customer shall compensate Supplier for glucometers that are inactive or <br /> retained and not returned to Supplier by members who are no longer eligible for <br /> receiving the services of the Supplier's diabetes program. Supplier shall report <br /> the number of ineligible and inactive members to the Customer on a quarterly <br /> basis (and identify their names, if requested, in accordance with HIPAA). <br /> If the member has used the glucometer for more than 12 months, no charges <br /> will occur. However, a one-time (i.e. life time) charge of $40.00 will be levied <br /> only if the member utilizes the glucometer for less than a twelve-month period <br /> either due to inactivity or ineligibility. Charges for lost glucometers requiring <br /> replacements are covered in Appendix C. <br /> 4. Amounts Payable to the Supplier <br /> a. To reimburse the Supplier for its products and services, the <br /> Customer will follow the prices and amounts detailed in Appendix <br /> C and pay K-Remedy (a wholly owned subsidiary of Supplier) for the <br /> services provided. K-Remedy is a national mail order diabetic <br /> supplies company, with the National Provider Identifier (NPI) #: <br /> 1922406388 and the National Council for Prescription Drug <br /> Programs (NCPDP) #: 3845421. <br /> b. The Supplier shall use the payment process as outlined in <br /> Appendix C (Rates, Claims & Payment Process for Direct <br /> Payment by Customer to Supplier). <br /> s. Survival <br /> The covenants, undertakings, and agreements contained in the <br /> Confidentiality/Nondisclosure section of this Purchase <br /> Agreement shall survive the termination of this Purchase <br /> Agreement. <br /> FINAL 2.4 AUGUST 3RD 2016 3 <br />
The URL can be used to link to this page
Your browser does not support the video tag.